Software Expansion Supports Additional Devices in Delivering Reliable and Effective ePRO Solutions

PITTSBURGH, April 22 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced the availability of DiaryPRO(R) 210, its proven electronic diary delivered on the Windows Mobile operating system and the Hewlett-Packard iPAQ(R) 210 device.

The new version features the same easy-to-use patient interface and electronic assessment capabilities that have been used by over 100,000 clinical trial subjects in international clinical development programs over the past ten years.

"We have leveraged our experience with the Windows Mobile operating system to port our proven DiaryPRO solution onto newer and more versatile hardware devices," said Tom Henson, invivodata's vice president of marketing. "It's important that our customers -- and, ultimately, clinical trial subjects -- continue to benefit from practical, intuitive ePRO features that will enable their trials to succeed, regardless of the underlying operating system or device implemented."

invivodata will demonstrate DiaryPRO 210 at ePROficiency(TM) 2009, the annual invivodata PRO Conference, which begins today in Naples, FL.

About invivodata inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

    For more information, contact:

    invivodata inc.
    Christine Tobin
    Corporate Communications Specialist
    (412) 390-3000, ext. 3502
    ctobin@invivodata.com

SOURCE invivodata inc.

Back to top

RELATED LINKS
http://www.invivodata.com